Clinical data
±
Mean HbA1c, total cholesterol, HDL, LDL, body mass index, systolic blood pressure, diastolic blood pressure, and log MAR visual acuity at the baseline and 3-month follow-up visit are provided in Mean ( ± standard deviation) for clinical variables measured at baseline and 3-month follow-up visit for participants in the intervention and the control group along with the results of 2 (participant groups) *2 (visits) ANOVA and the Bonferroni corrected Overall, in 92.7% of the participants in the intervention group and 60% of those in the control group, the HbA1c level was found to decrease from the baseline to three months follow-up visit. In the intervention group, the mean HbA1c averaged across the participants decreased from 7.2% at baseline to 6.1% at the 3-month visit. In the control group, it decreased from 7.1% at baseline to 6.6% at 3-month visit. A two (participant groups) × two (visits) mixed ANOVA on HbA1c data showed a significant main effect for visit, but not for participant group (Above. Scatterplot showing the HbA1c for individual participants at baseline against 3-month follow-up visit. Below. Showing the mean HbA1c for the participant groups at baseline and 3-month follow-up visit. Error bars represent 95% CI.A two (participant groups) × two (visits) mixed ANOVA on total cholesterol did not show a significant main effect of the participant group and visit, but a significant interaction between effects of participant group and visit type was found (Above. Scatterplot showing the total cholesterol for individual participants at baseline against 3-month follow-up visit. Below. Showing the mean total cholesterol for the participant groups at baseline and 3-month follow-up visit. Error bars represent 95% CI.A significant interaction between the effects of the participant group (intervention and control) and the type of visit (baseline and 3-month follow-up) was also found for LDL levels, Above. Scatterplot showing the LDL for individual participants at baseline and 3-month follow-up visit. Below. Showing the mean LDL for the participant groups at baseline and 3-month follow-up visit. Error bars represent 95% CI.The mean HDL between the baseline and 3-month visit did not differ significantly between the participant groups, nor did other clinical variables including log MAR visual acuity, BMI, and systolic and diastolic blood pressure.